{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:58:14Z","timestamp":1793059094128,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T00:00:00Z","timestamp":1417996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T00:00:00Z","timestamp":1417996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep07336","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T10:24:30Z","timestamp":1418034270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Mutations of epigenetic regulatory genes are common in thymic carcinomas"],"prefix":"10.1038","volume":"4","author":[{"given":"Yisong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Keith","family":"Killian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,8]]},"reference":[{"key":"BFsrep07336_CR1","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","volume":"5","author":"EA Engels","year":"2010","unstructured":"Engels, E. A. Epidemiology of thymoma and associated malignancies. J Thorac Oncol 5, S260\u2013265 (2010).","journal-title":"J Thorac Oncol"},{"key":"BFsrep07336_CR2","unstructured":"Travis, W. D., Brambilla, E., Muller-Hermelink, H. K. & Harris, C. C. Pathology and genetics: Tumors of the lung, pleura, thymus and heart. in World Health Organization Classification of Tumours (series eds. Kleihues, P. & Sobin, L. H.) 145\u2013247 (IARC Press, Lyon, 2004)."},{"key":"BFsrep07336_CR3","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","volume":"29","author":"RJ Kelly","year":"2011","unstructured":"Kelly, R. J., Petrini, I., Rajan, A., Wang, Y. & Giaccone, G. Thymic Malignancies: From Clinical Management to Targeted Therapies. J Clin Oncol 29, 4820\u20134827 (2011).","journal-title":"J Clin Oncol"},{"key":"BFsrep07336_CR4","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1200\/JCO.2009.27.4944","volume":"28","author":"LE Macconaill","year":"2010","unstructured":"Macconaill, L. E. & Garraway, L. A. Clinical implications of the cancer genome. J Clin Oncol 28, 5219\u20135228 (2010).","journal-title":"J Clin Oncol"},{"key":"BFsrep07336_CR5","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.1200\/jco.2014.32.15_suppl.7525","volume":"32:5s","author":"A Thomas","year":"2014","unstructured":"Thomas, A. et al. Phase II trial of sunitinib in patients with thymic epithelial tumors (TET). J Clin Oncol 32:5s, suppl; abstr 7525\u20137525 (2014).","journal-title":"J Clin Oncol"},{"key":"BFsrep07336_CR6","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.1200\/jco.2014.32.15_suppl.7526","volume":"32:5s","author":"B Besse","year":"2014","unstructured":"Besse, B. et al. A phase II study of milciclib (PHA-848125AC) in patients (pts) with thymic carcinoma (TC). J Clin Oncol 32:5s, Suppl; abstr 7526\u20137526 (2014).","journal-title":"J Clin Oncol"},{"key":"BFsrep07336_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1470-2045(13)70596-5","volume":"15","author":"A Rajan","year":"2014","unstructured":"Rajan, A. et al. Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial. Lancet Oncol 15, 191\u2013200 (2014).","journal-title":"Lancet Oncol"},{"key":"BFsrep07336_CR8","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1200\/JCO.2010.32.4467","volume":"29","author":"G Giaccone","year":"2011","unstructured":"Giaccone, G. et al. Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors. J Clin Oncol 29, 2052\u20132059 (2011).","journal-title":"J Clin Oncol"},{"key":"BFsrep07336_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrg2841","volume":"11","author":"M Meyerson","year":"2010","unstructured":"Meyerson, M., Gabriel, S. & Getz, G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 11, 685\u2013696 (2010).","journal-title":"Nat Rev Genet"},{"key":"BFsrep07336_CR10","doi-asserted-by":"publisher","first-page":"S291","DOI":"10.1097\/JTO.0b013e3181f209b9","volume":"5","author":"N Girard","year":"2010","unstructured":"Girard, N. Thymic tumors: relevant molecular data in the clinic. J Thorac Oncol 5, S291\u2013295 (2010).","journal-title":"J Thorac Oncol"},{"key":"BFsrep07336_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"BFsrep07336_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501, 338\u2013345 (2013).","journal-title":"Nature"},{"key":"BFsrep07336_CR13","doi-asserted-by":"publisher","first-page":"e60572","DOI":"10.1371\/journal.pone.0060572","volume":"8","author":"I Petrini","year":"2013","unstructured":"Petrini, I. et al. Whole genome and transcriptome sequencing of a B3 thymoma. PloS One 8, e60572 (2013).","journal-title":"PloS One"},{"key":"BFsrep07336_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ng.3016","volume":"46","author":"I Petrini","year":"2014","unstructured":"Petrini, I. et al. A specific missense mutation in GTF2i occurs at high frequency in thymic epithelial tumors. Nat Genet 46, 844\u2013849 (2014).","journal-title":"Nat Genet"},{"key":"BFsrep07336_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","volume":"7","author":"E Vilar","year":"2010","unstructured":"Vilar, E. & Gruber, S. B. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol 7, 153\u2013162 (2010).","journal-title":"Nat Rev Clin Oncol"},{"key":"BFsrep07336_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/12257","volume":"6","author":"PA Rice","year":"1999","unstructured":"Rice, P. A. Holding damaged DNA together. Nat Struct Biol 6, 805\u2013806 (1999).","journal-title":"Nat Struct Biol"},{"key":"BFsrep07336_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4, 1073\u20131081 (2009).","journal-title":"Nat Protoc"},{"key":"BFsrep07336_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat Methods 7, 248\u2013249 (2010).","journal-title":"Nat Methods"},{"key":"BFsrep07336_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/ajcp\/104.4.375","volume":"104","author":"H Tateyama","year":"1995","unstructured":"Tateyama, H. et al. p53 protein expression and p53 gene mutation in thymic epithelial tumors. An immunohistochemical and DNA sequencing study. Am J Clin Pathol 104, 375\u2013381 (1995).","journal-title":"Am J Clin Pathol"},{"key":"BFsrep07336_CR20","doi-asserted-by":"publisher","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","volume":"14","author":"C Beadling","year":"2008","unstructured":"Beadling, C. et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 14, 6821\u20136828 (2008).","journal-title":"Clin Cancer Res"},{"key":"BFsrep07336_CR21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/humu.21024","volume":"30","author":"PW Blake","year":"2009","unstructured":"Blake, P. W. & Toro, J. R. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling. Hum Mutat 30, 1025\u20131036 (2009).","journal-title":"Hum Mutat"},{"key":"BFsrep07336_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/cdd.2009.43","volume":"17","author":"SC Sun","year":"2010","unstructured":"Sun, S. C. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ 17, 25\u201334 (2010).","journal-title":"Cell Death Differ"},{"key":"BFsrep07336_CR23","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546\u20131558 (2013).","journal-title":"Science"},{"key":"BFsrep07336_CR24","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pena-Llopis","year":"2012","unstructured":"Pena-Llopis, S. et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 44, 751\u2013759 (2012).","journal-title":"Nat Genet"},{"key":"BFsrep07336_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone, M. et al. BAP1 and cancer. Nat Rev Cancer 13, 153\u2013159 (2013).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep07336_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/leu.2012.288","volume":"27","author":"O Abdel-Wahab","year":"2013","unstructured":"Abdel-Wahab, O. & Dey, A. The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics. Leukemia 27, 10\u201315 (2013).","journal-title":"Leukemia"},{"key":"BFsrep07336_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cell.2013.04.018","volume":"153","author":"CK Schmidt","year":"2013","unstructured":"Schmidt, C. K. & Jackson, S. P. On your mark, get SET(D2), go! H3K36me3 primes DNA mismatch repair. Cell 153, 513\u2013515 (2013).","journal-title":"Cell"},{"key":"BFsrep07336_CR28","doi-asserted-by":"publisher","first-page":"e004","DOI":"10.1621\/nrs.06004","volume":"6","author":"KW Trotter","year":"2008","unstructured":"Trotter, K. W. & Archer, T. K. The BRG1 transcriptional coregulator. Nucl Recept Signal 6, e004 (2008).","journal-title":"Nucl Recept Signal"},{"key":"BFsrep07336_CR29","doi-asserted-by":"crossref","unstructured":"de la Fouchardiere, A. et al. Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin Genet, 10.1111\/cge.12472 (2014).","DOI":"10.1111\/cge.12472"},{"key":"BFsrep07336_CR30","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1038\/oncsis.2014.25","volume":"3","author":"R Belani","year":"2014","unstructured":"Belani, R. et al. ASXL1 and DNMT3A mutation in a cytogenetically normal B3 thymoma. Oncogenesis 3, e111 (2014).","journal-title":"Oncogenesis"},{"key":"BFsrep07336_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-8722-5-12","volume":"5","author":"V Gelsi-Boyer","year":"2012","unstructured":"Gelsi-Boyer, V., Brecqueville, M., Devillier, R., Murati, A., Mozziconacci, M. J. & Birnbaum, D. Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases. J Hematol & Oncol 5, 12 (2012).","journal-title":"J Hematol & Oncol"},{"key":"BFsrep07336_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nature08672","volume":"463","author":"GL Dalgliesh","year":"2010","unstructured":"Dalgliesh, G. L. et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463, 360\u2013363 (2010).","journal-title":"Nature"},{"key":"BFsrep07336_CR33","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1038\/ncomms4630","volume":"5","author":"R Huether","year":"2014","unstructured":"Huether, R. et al. The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat Commun 5, 3630 (2014).","journal-title":"Nat Commun"},{"key":"BFsrep07336_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1056\/NEJMc1111708","volume":"366","author":"L Couronne","year":"2012","unstructured":"Couronne, L., Bastard, C. & Bernard, O. A. TET2 and DNMT3A mutations in human T-cell lymphoma. New Engl J Med 366, 95\u201396 (2012).","journal-title":"New Engl J Med"},{"key":"BFsrep07336_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/hmg\/dds403","volume":"22","author":"M Szemes","year":"2013","unstructured":"Szemes, M. et al. Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A. Hum Mol Genet 22, 74\u201383 (2013).","journal-title":"Hum Mol Genet"},{"key":"BFsrep07336_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/leu.2013.337","volume":"28","author":"E Solary","year":"2014","unstructured":"Solary, E., Bernard, O. A., Tefferi, A., Fuks, F. & Vainchenker, W. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia 28, 485\u2013496 (2014).","journal-title":"Leukemia"},{"key":"BFsrep07336_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/ng.788","volume":"43","author":"XJ Yan","year":"2011","unstructured":"Yan, X. J. et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet 43, 309\u2013315 (2011).","journal-title":"Nat Genet"},{"key":"BFsrep07336_CR38","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley, T. J. et al. DNMT3A mutations in acute myeloid leukemia. New Engl J Med 363, 2424\u20132433 (2010).","journal-title":"New Engl J Med"},{"key":"BFsrep07336_CR39","doi-asserted-by":"publisher","first-page":"7103","DOI":"10.1200\/jco.2012.30.4_suppl.252","volume":"30","author":"A Thomas","year":"2012","unstructured":"Thomas, A. et al. A phase (Ph) I\/II study of belinostat (Bel) in combination with cisplatin, doxorubicin and cyclophosphamide (PAC) in the first-line treatment of advanced or recurrent thymic malignancies. J Clin Oncol 30, suppl; abstr 7103\u20137103 (2012).","journal-title":"J Clin Oncol"},{"key":"BFsrep07336_CR40","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00018-009-0177-1","volume":"67","author":"P Nicholson","year":"2010","unstructured":"Nicholson, P. et al. Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol life Sci 67, 677\u2013700 (2010).","journal-title":"Cell Mol life Sci"},{"key":"BFsrep07336_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1470-2045(12)70584-3","volume":"14","author":"P Kapur","year":"2013","unstructured":"Kapur, P. et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol 14, 159\u2013167 (2013).","journal-title":"Lancet Oncol"},{"key":"BFsrep07336_CR42","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/2159-8290.CD-11-0214","volume":"1","author":"RA Juergens","year":"2011","unstructured":"Juergens, R. A. et al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov 1, 598\u2013607 (2011).","journal-title":"Cancer Discov"},{"key":"BFsrep07336_CR43","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1182\/blood-2013-02-474833","volume":"121","author":"T Neff","year":"2013","unstructured":"Neff, T. & Armstrong, S. A. Recent progress toward epigenetic therapies: the example of mixed lineage leukemia. Blood 121, 4847\u20134853 (2013).","journal-title":"Blood"},{"key":"BFsrep07336_CR44","doi-asserted-by":"publisher","first-page":"583929","DOI":"10.1155\/2011\/583929","volume":"2011","author":"A Mogi","year":"2011","unstructured":"Mogi, A. & Kuwano, H. TP53 mutations in nonsmall cell lung cancer. J Biomed Biotechnol 2011, 583929 (2011).","journal-title":"J Biomed Biotechnol"},{"key":"BFsrep07336_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1183\/09031936.00097311","volume":"40","author":"C Scoccianti","year":"2012","unstructured":"Scoccianti, C. et al. Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort. ERJ 40, 177\u2013184 (2012).","journal-title":"ERJ"},{"key":"BFsrep07336_CR46","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nature01811","volume":"424","author":"TR Brummelkamp","year":"2003","unstructured":"Brummelkamp, T. R., Nijman, S. M., Dirac, A. M. & Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424, 797\u2013801 (2003).","journal-title":"Nature"},{"key":"BFsrep07336_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/01.COT.0000290991.23049.55","volume":"25","author":"N Pfeiffer","year":"2003","unstructured":"Pfeiffer, N. Topical aspirin promising against rare inherited skin cancer. Oncol Times 25, 42\u201345 (2003).","journal-title":"Oncol Times"},{"key":"BFsrep07336_CR48","doi-asserted-by":"crossref","unstructured":"Giaccone, G. et al. Custom (Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer and Thymic Malignancies) trial. J Clin Oncol 31, suppl; abstr 7513\u20137513 (2013).","DOI":"10.1200\/jco.2013.31.15_suppl.7513"},{"key":"BFsrep07336_CR49","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"BFsrep07336_CR50","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811\u20131817 (2012).","journal-title":"Bioinformatics"},{"key":"BFsrep07336_CR51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6, 80\u201392 (2012).","journal-title":"Fly"},{"key":"BFsrep07336_CR52","doi-asserted-by":"publisher","first-page":"E2393","DOI":"10.1002\/humu.22376","volume":"34","author":"X Liu","year":"2013","unstructured":"Liu, X., Jian, X. & Boerwinkle, E. dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. Hum Mutat 34, E2393\u20132402 (2013).","journal-title":"Hum Mutat"},{"key":"BFsrep07336_CR53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc, Series B 57, 289\u2013300 (1995).","journal-title":"J R Stat Soc, Series B"},{"key":"BFsrep07336_CR54","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Pro Natl Acad Sci USA 100, 9440\u20139445 (2003).","journal-title":"Pro Natl Acad Sci USA"},{"key":"BFsrep07336_CR55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","volume":"5","author":"R Ihaka","year":"1996","unstructured":"Ihaka, R. & Gentleman, R. R. A language for data analysis and graphics. J Comut Graph Stat 5, 299\u2013314 (1996).","journal-title":"J Comut Graph Stat"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep07336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07336","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T17:58:31Z","timestamp":1717610311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep07336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,8]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep07336"],"URL":"https:\/\/doi.org\/10.1038\/srep07336","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,8]]},"assertion":[{"value":"8 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7336"}}